These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 15166483)
21. Cortisol responses to the insulin hypoglycaemia test in children. Crofton PM; Don-Wauchope AC; Bath LE; Kelnar CJ Horm Res; 2004; 61(2):92-7. PubMed ID: 14646394 [TBL] [Abstract][Full Text] [Related]
22. Cortisol Levels in Glucagon Stimulation Test in Children Assessed for Short Stature: Clinical and Laboratorial Correlations. Maliachova O; Dimitriadou M; Triantafyllou P; Slavakis A; Christoforidis A Horm Metab Res; 2019 Dec; 51(12):798-804. PubMed ID: 31745940 [TBL] [Abstract][Full Text] [Related]
23. [Sensitivity of the clonidine and guanfacine tests (alpha-2-adrenergic agonists) as pharmacologic stimulants of growth hormone. Effects on plasma cortisol]. Durá Travé T; Juste Ruiz M; González Montero R; Gutiérrez Terán M; Mauri Dot M; Moya Benavent M An Esp Pediatr; 1996 Dec; 45(6):575-8. PubMed ID: 9133220 [TBL] [Abstract][Full Text] [Related]
24. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin? Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233 [TBL] [Abstract][Full Text] [Related]
25. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study. Moore WV; Dana K; Frane J; Lippe B Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719 [TBL] [Abstract][Full Text] [Related]
26. L-dopa is a potent stimulator of cortisol in short children. Marakaki C; Papadimitriou DT; Papadopoulou A; Fretzayas A; Papadimitriou A Horm Res Paediatr; 2014; 81(6):386-90. PubMed ID: 24802138 [TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Agha A; Rogers B; Mylotte D; Taleb F; Tormey W; Phillips J; Thompson CJ Clin Endocrinol (Oxf); 2004 May; 60(5):584-91. PubMed ID: 15104561 [TBL] [Abstract][Full Text] [Related]
28. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781 [TBL] [Abstract][Full Text] [Related]
29. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa. Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371 [TBL] [Abstract][Full Text] [Related]
30. [Growth hormone response to insulin-induced hypoglycaemia in children with normal stature or normal variant short stature]. Zdravković D; Banićević M; Subotić Z; Maksimović R Srp Arh Celok Lek; 1994; 122(1-2):1-4. PubMed ID: 17972789 [TBL] [Abstract][Full Text] [Related]
31. Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease. Wilson JR; Utz AL; Devin JK Growth Horm IGF Res; 2016 Feb; 26():24-31. PubMed ID: 26774402 [TBL] [Abstract][Full Text] [Related]
32. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight. Di Cesare Merlone A; Bozzola E; Castelnovi C; Chiabotto P; Costante L; De Sanctis L; Tinelli C; Bozzola M Horm Res; 2005; 63(2):102-6. PubMed ID: 15767761 [TBL] [Abstract][Full Text] [Related]
33. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO; Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181 [TBL] [Abstract][Full Text] [Related]
34. Glucose, growth hormone, cortisol, and insulin responses to glucagon injection in normal infants, aged 0.5-12 months. Chanoine JP; Rebuffat E; Kahn A; Bergmann P; Van Vliet G J Clin Endocrinol Metab; 1995 Oct; 80(10):3032-5. PubMed ID: 7559892 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the clinical utility of the ultrasensitive immunofluometric assay for growth hormone (GH) and of the cortisol secretory pattern in prediction of the linear growth response to treatment with GH. Root AW; Duckett GE; Geiszler JE; Hu CS; Bercu BB J Pediatr Endocrinol Metab; 1997; 10(1):3-10. PubMed ID: 9364336 [TBL] [Abstract][Full Text] [Related]
36. The intramuscular glucagon stimulation test does not provide good discrimination between normal and inadequate ACTH reserve when used in the investigation of short healthy children. Tenenbaum A; Phillip M; de Vries L Horm Res Paediatr; 2014; 82(3):194-200. PubMed ID: 25139316 [TBL] [Abstract][Full Text] [Related]
37. The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21. Akkar I; Karaca Z; Taheri S; Unluhizarci K; Hacioglu A; Kelestimur F Endocrine; 2022 Jan; 75(1):211-218. PubMed ID: 34562190 [TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults. Yuen KC; Biller BM; Katznelson L; Rhoads SA; Gurel MH; Chu O; Corazzini V; Spiller K; Gordon MB; Salvatori R; Cook DM Pituitary; 2013 Jun; 16(2):220-30. PubMed ID: 22806554 [TBL] [Abstract][Full Text] [Related]